Sign in or Register   Sign in or Register
  |  

Mouse Anti-COL4A3 Recombinant Antibody (CBCNC-272) (CBMAB-C2633-CN)

This product is a Mouse antibody that recognizes COL4A3. The antibody CBCNC-272 can be used for immunoassay techniques such as: WB, ICC, IHC-P, IHC-F, ELISA.
See all COL4A3 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBCNC-272
Application
WB, ICC, IHC-P, IHC-F, ELISA

Basic Information

Immunogen
Collagen Type IV Alpha 3
Specificity
Human
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Buffer
PBS, pH 7.4, 50% glycerol
Preservative
0.02% Sodium azide
Concentration
0.5 mg/mL

Target

Full Name
Collagen Type IV Alpha 3 Chain
Introduction
COL4A3 (Collagen Type IV Alpha 3 Chain) is a Protein Coding gene. Diseases associated with COL4A3 include Alport Syndrome, Autosomal Dominant and Hematuria, Benign Familial. Among its related pathways are Primary Focal Segmental Glomerulosclerosis FSGS and Integrin Pathway. Gene Ontology (GO) annotations related to this gene include structural molecule activity and extracellular matrix structural constituent. An important paralog of this gene is COL4A5.
Entrez Gene ID
1285
UniProt ID
Q01955
Alternative Names
Collagen Type IV Alpha 3 Chain; Collagen, Type IV, Alpha 3 (Goodpasture Antigen); Tumstatin; Collagen IV, Alpha-3 Polypeptide; Collagen Alpha-3(IV) Chain; Goodpasture Antigen;
Function
Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.

Tumstatin, a cleavage fragment corresponding to the collagen alpha 3(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity; these two anti-tumor properties may be regulated via RGD-independent ITGB3-mediated mechanisms.
Biological Process
Activation of cysteine-type endopeptidase activity involved in apoptotic process Source: UniProtKB
Blood circulation Source: ProtInc
Cell adhesion Source: UniProtKB-KW
Cell surface receptor signaling pathway Source: UniProtKB
Collagen-activated tyrosine kinase receptor signaling pathway Source: Ensembl
Collagen fibril organization Source: Reactome
Endothelial cell apoptotic process Source: UniProtKB
Extracellular matrix organization Source: GO_Central
Glomerular basement membrane development Source: UniProtKB
Negative regulation of angiogenesis Source: UniProtKB
Negative regulation of cell population proliferation Source: ProtInc
Negative regulation of vascular endothelial cell proliferation Source: UniProtKB
Response to glucose Source: Ensembl
Sensory perception of sound Source: ProtInc
Cellular Location
Basement membrane. Colocalizes with COL4A4 and COL4A5 in GBM, tubular basement membrane (TBM) and synaptic basal lamina (BL).
Involvement in disease
Autoantibodies against the NC1 domain of alpha 3(IV) are found in Goodpasture syndrome, an autoimmune disease of lung and kidney.
Alport syndrome 2, autosomal recessive (ATS2):
A syndrome characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness.
Hematuria, benign familial (BFH):
An autosomal dominant condition characterized by non-progressive isolated microscopic hematuria that does not result in renal failure. It is characterized pathologically by thinning of the glomerular basement membrane.
Alport syndrome 3, autosomal dominant (ATS3):
A syndrome characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness.
PTM
Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
Isoform 2 contains an additional N-linked glycosylation site.
Type IV collagens contain numerous cysteine residues which are involved in inter- and intramolecular disulfide bonding. 12 of these, located in the NC1 domain, are conserved in all known type IV collagens.
The trimeric structure of the NC1 domains is stabilized by covalent bonds between Lys and Met residues.
Phosphorylated. Thought to be phosphorylated by CERT, but CERT does not have kinase activity.

Alves, A. P. V., Freitas, A. B., Levi, J. E., Amorim Filho, A. G., Franco, L. A., Hoshida, M. S., ... & Carvalho, M. H. B. (2021). COL1A1, COL4A3, TIMP2 and TGFB1 polymorphisms in cervical insufficiency. Journal of Perinatal Medicine, 49(5), 553-558.

Barua, M., & Paterson, A. D. (2021). Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria. Pediatric Nephrology, 1-10.

Mamoor, S. (2021). COL4A3 is differentially expressed in the lymph nodes of patients with metastatic breast cancer.

Odiatis, C., Savva, I., Pieri, M., Ioannou, P., Petrou, P., Papagregoriou, G., ... & Deltas, C. (2021). A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome. Matrix biology plus, 9, 100053.

Funk, S. D., Bayer, R. H., & Miner, J. H. (2019). Endothelial cell-specific collagen type IV-α3 expression does not rescue Alport syndrome in Col4a3−/− mice. American Journal of Physiology-Renal Physiology, 316(5), F830-F837.

Rønnow, S. R., Sand, J. M. B., Langholm, L. L., Manon-Jensen, T., Karsdal, M. A., Tal-Singer, R., ... & Leeming, D. J. (2019). Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort. Respiratory research, 20(1), 1-10.

Jessen, H., Rønnow, S. R., Langholm, L., Gudmann, N. S., Karsdal, M., Manon-Jensen, T., ... & Leeming, D. J. (2019). Collagen Type IV Degradation Predicts Mortality in the Eclipse COPD Cohort. In B93. COPD: MORTALITY AND RISK PREDICTION (pp. A4001-A4001). American Thoracic Society.

Saravani, R., Yari, D., Saravani, S., & Hasanian-Langroudi, F. (2017). Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus. Japanese journal of ophthalmology, 61(3), 218-222.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-COL4A3 Recombinant Antibody (CBCNC-272)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare